Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Inmagene Approved to Start US Trials of HutchMed Immune Disease Therapy

publication date: May 2, 2022

Shanghai Inmagene Biopharmaceuticals was approved to start US trials of an OX40 mAb that targets immune diseases including atopic dermatitis. Inmagene is developing IMG-007 in partnership with HutchMed and has an exclusive option to in-license the candidate. In 2021, Inmagene in-licensed global rights to four novel pre-clinical immunological candidates from HutchMed in a $920 million deal. The two companies partner pre-clinical development, while Inmagene is responsible for global clinical trials. IMG-007 is designed to inhibit binding of OX40 to OX40L reducing T cell release. More details....

Stock Symbols: (NSDQ/AIM: HCM; HK:13)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here